we take that responsibility very seriously. We believe we owe our equipment users and their patients - not to mention our investors, employees and other stakeholders - an appropriate reaction to the Tribune article. We are issuing this statement today so that it is fed into the cyber universe of archived information and hopefully can be seen by readers of the Tribune article, next week or next year, in Pittsburgh or twelve time zones away.
"The Tribune article also noted our collaboration with the U.S. military to improve detection of mild traumatic brain injuries (mTBI) suffered by soldiers returning from Afghanistan and Iraq. We appreciate the Tribune's coverage of our work in this field."
ABOUT NEURO KINETICS, INC.
Neuro Kinetics, Inc. (www.neuro-kinetics.com) is a fast-growing manufacturer of noninvasive medical test equipment used worldwide by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists in the detection and evaluation of neurological, otological and vestibular disorders. The privately owned company, originating in the 1970s, pioneered the development of vestibular and neuro-otologic testing equipment, including the renowned Barany (rotational) chair. The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center) system, I-Portal® VNG (Video Nystagmography) system and I-Portal® VOG (Video Oculography) system, along with related accessories, software, training and support services. Users include doctors and researchers in universities and government facilities as well as specialists in fields such as audiology, neurology, neuro-otology, ophthalmology and otolaryngology.
MEDIA CONTACT
John Buckman
Buckman Communications, for Neuro Kinetics, Inc.
+ 1 412-381-2900 or '/>"/>
SOURCE Neuro Kinetics, Inc Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
NeurogesX Expands Commercial Operations Leadership Team2.
Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference3.
Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascents Neurogenesis Platform4.
NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results5.
Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology6.
Neuro Kinetics & Military Researchers in Push To Improve Diagnosis & Treatment of Combat Brain Injuries7.
Neurocrine Biosciences Reports Third Quarter 2009 Results8.
Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR9.
Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results10.
Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org11.
After a Stroke, When Seconds Count, Innovative Device from NeuroInterventions Speedily Restores Brains Blood Flow